All In Biotech

Drug Trial Radar · NCT05571059

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Determine the Safety and Efficacy of Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 128 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

128

Planned (sponsor's estimate)

Start

Jan 31, 2024

Primary completion

Jan 2028

Study completion Jan 2028

Sponsor

Lead sponsor
Cumberland PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Oct 7, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF.

Conditions

  • Idiopathic Pulmonary Fibrosis

Interventions

  • Ifetroban SodiumDrug

    Once daily oral ifetroban

  • PlaceboDrug

    Matching oral placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in Forced Vital Capacity (FVC) in mLTime frame: Baseline through 12 months

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Biosolutions Clinical Research

    La Mesa, California · Active not recruiting

  • University of California San Francisco

    San Francisco, California · Recruiting

  • UConn Health

    Farmington, Connecticut · Recruiting

  • Mayo Clinic Jacksonville

    Jacksonville, Florida · Recruiting

  • Miami VA Health System

    Miami, Florida · Recruiting

  • Northwestern Medicine

    Chicago, Illinois · Recruiting

  • Indiana University Health

    Indianapolis, Indiana · Recruiting

  • University of Kansas

    Kansas City, Kansas · Recruiting

  • University of Louisville

    Louisville, Kentucky · Recruiting

  • Beaumont Hospital, Royal Oak

    Royal Oak, Michigan · Recruiting

  • Icahn School of Medicine at Mount Sinai

    New York, New York · Recruiting

  • University of Rochester

    Rochester, New York · Recruiting

  • UNC Chapel Hill

    Chapel Hill, North Carolina · Recruiting

  • Bend Memorial Hospital

    Bend, Oregon · Recruiting

  • Temple University Hospital

    Philadelphia, Pennsylvania · Recruiting

  • Avera Research Institute

    Sioux Falls, South Dakota · Recruiting

  • Pulmonary & Sleep Specialists

    Dickson, Tennessee · Active not recruiting

  • Baylor University Medical Center

    Dallas, Texas · Recruiting

  • Premier Pulmonary Critical Care and Sleep Medicine

    Denison, Texas · Recruiting

  • UW Health University Hospital

    Madison, Wisconsin · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.